b
r
c
rna
interfer
rnai
natur
mechan
suppress
silenc
express
aberr
foreign
gene
power
antivir
strategi
wide
employ
protect
host
viral
infect
hepat
e
acut
fulmin
hepat
adult
particularli
high
mortal
pregnant
women
point
time
vaccin
antivir
treatment
effect
infecti
agent
hev
nonstructur
polyprotein
region
possess
rnadepend
rna
polymeras
rdrp
respons
replic
viral
rna
genom
rdrp
therefor
regard
one
attract
candid
rna
interfer
rnai
present
studi
high
effici
specif
sirna
evalu
realtim
quantit
pcr
western
blot
assay
protect
effect
hev
infect
achiev
cell
piglet
piglet
treat
express
plasmid
prior
hev
inocul
hev
antigen
significantli
reduc
liver
spleen
kidney
activ
alanin
aminotransferas
alt
aspart
aminotransferas
ast
total
bilirubin
tbil
clearli
decreas
result
suggest
rnai
potenti
effect
antivir
strategi
hev
replic
infect
hepat
e
viru
hev
caus
agent
acut
fulmin
hepat
e
enter
zoonot
diseas
transmit
across
speci
human
pig
cat
chicken
deer
rodent
arankal
et
al
feagin
et
al
gardner
luciw
huang
et
al
okamoto
et
al
tei
et
al
vitral
et
al
although
hev
transmit
predominantli
fecalor
rout
kasorndorkbua
et
al
preval
mainli
promot
contamin
water
krawczynski
et
al
hsieh
et
al
hev
outbreak
occur
sever
time
result
huge
econom
loss
develop
countri
asia
africa
mexico
hev
nonenvelop
singlestrand
positivestrand
rna
viru
genom
length
kb
genom
contain
three
major
open
read
frame
orf
encod
nonstructur
polyprotein
includ
methyltransferas
proteas
rna
helicas
rnadepend
rna
polymeras
rdrp
replicas
jameel
panda
et
al
rdrp
catalyz
viral
replic
agraw
et
al
play
key
role
life
cycl
rna
virus
activ
hev
rdrp
experiment
demonstr
previou
studi
agraw
et
al
ansari
et
al
panda
et
al
initi
replic
hev
confirm
requir
interact
end
hev
genom
rdrp
well
host
cell
synthesi
minusstrand
replic
intermedi
agraw
et
al
intermedi
act
subgenom
promot
transcript
structur
region
mrna
jameel
nanda
et
al
addit
nucleotid
sequenc
conserv
genom
region
hev
strain
four
genotyp
zhai
et
al
therefor
rdrp
gene
expect
prime
potenti
target
develop
antivir
strategi
vaccin
previous
consid
best
strategi
prevent
hev
infect
four
hev
genotyp
singl
serotyp
mushahwar
panda
et
al
howev
earlier
evid
document
despit
presenc
antibodi
hev
capsid
protein
hev
still
capabl
caus
infect
panda
et
al
yarbough
moreov
although
vaccineinduc
antibodi
might
attenu
hev
infect
may
prevent
viru
excret
fece
panda
et
al
reason
protect
neutral
antibodi
either
develop
shortliv
jameel
yarbough
recent
purifi
polypeptid
vaccin
produc
insect
cell
infect
recombin
baculoviru
contain
truncat
hev
genom
sequenc
encod
capsid
antigen
complet
phase
trial
abreu
krawczynski
mushahwar
shrestha
et
al
howev
safeti
efficaci
vaccin
doubt
tack
trautwein
first
subject
exclus
male
pregnant
women
infect
hev
highest
mortal
secondli
inconsist
data
human
rhesu
monkey
krawczynski
tack
trautwein
final
pig
still
suffer
hev
within
day
postinfect
transmit
viru
earli
first
week
postinfect
continu
least
sever
week
halbur
et
al
howev
current
vaccin
provid
complet
protect
prior
month
shrestha
et
al
thu
urgent
develop
effect
safer
therapeut
strategi
hev
control
rnai
selfdefens
mechan
present
eukaryot
cell
specif
prevent
infect
induc
virus
plasterk
inhibit
express
crucial
viral
protein
directli
target
viral
mrna
degrad
gitlin
et
al
shabalina
koonin
wide
use
suppress
viral
replic
posttranscript
regul
gene
express
success
appli
infect
inhibit
studi
virus
human
immunodefici
viru
hiv
kumar
et
al
ludwig
saayman
et
al
ter
brake
et
al
hepat
c
viru
hcv
demarini
et
al
lupberg
et
al
well
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
lu
et
al
ni
et
al
present
studi
rnai
potenti
antivir
therapeut
strategi
target
rdrp
gene
use
inhibit
hev
replic
vitro
cell
vivo
piglet
posit
hev
character
genotyp
genbank
access
isol
swine
fece
shanghai
suburb
china
use
templat
revers
transcript
nest
polymeras
chain
reaction
pcr
rtnpcr
amplifi
rdrp
gene
base
pair
extern
forward
primer
revers
primer
respect
intern
forward
primer
revers
primer
respect
rtnpcr
analysi
conduct
use
amv
revers
transcriptas
xl
rtpcr
takara
japan
accord
manufactur
direct
revers
transcript
reaction
protocol
perform
c
min
c
l
cdna
result
amplifi
nest
pcr
c
min
follow
c
c
c
min
repeat
cycl
pcr
product
detect
agaros
gel
contain
gml
ethidium
bromid
amplifi
dna
fragment
insert
multiclon
site
eukaryot
express
vector
contain
report
gene
enhanc
green
fluoresc
protein
egfp
use
standard
clone
procedur
restrict
site
bamhi
c
digest
bstxi
c
digest
egfp
gene
locat
downstream
target
gene
four
small
interf
rna
sirna
target
rdrp
gene
design
accord
qiagen
guidelin
http
wwwqiagencom
sequenc
shown
tabl
sirna
duplex
design
use
hiperform
design
algorithm
licens
novarti
ag
integr
stringent
inhous
homolog
analysi
tool
highestrank
sirna
duplex
gener
algorithm
chosen
repr
sent
best
combin
activ
specif
scrambl
sirna
construct
random
sequenc
heterolog
hev
sequenc
serv
neg
control
identif
specif
hev
sirna
gapdh
sirna
serv
control
experi
confirm
transfect
procedur
cell
cultur
support
gene
silenc
sirna
dilut
rnasefre
buffer
obtain
solut
solut
denatur
heat
c
min
incub
c
min
either
use
immedi
store
c
rnasefre
environ
correspond
small
hairpin
rna
shrna
express
vector
contain
human
polymeras
iii
pol
iii
promot
neomycin
resist
gene
neor
mcintyr
fan
saayman
et
al
construct
extract
endofre
plasmid
maxi
kit
omega
america
cell
line
use
studi
cell
trypsin
use
per
well
dilut
l
antibioticfre
growth
medium
plate
cell
confluent
time
transfect
one
microgram
recombin
plasmid
nm
sirna
l
transfect
use
l
lipofectamin
invitrogen
america
accord
manufactur
instruct
four
six
hour
posttransfect
cell
cultur
replac
fresh
growth
medium
optim
combin
four
paramet
cell
line
includ
highest
transfect
effici
lowest
nonspecif
effect
condit
effici
deliveri
sirna
concentr
lipofectamin
first
determin
preliminari
experiment
cell
incub
c
h
mrna
express
level
observ
h
protein
express
level
determin
transfect
suppress
effici
assess
measur
egfp
fluoresc
intens
transfect
cell
invert
fluoresc
microscop
nikon
japan
empti
vector
plasmid
transfect
sirna
test
nonspecif
effect
scrambl
sirna
use
establish
specif
gapdh
sirna
use
criterion
effici
inhibit
control
determin
cytotox
induc
transfect
hev
success
cultur
line
cell
previous
describ
huang
et
al
lorenzo
et
al
tanaka
et
al
cell
show
typic
cytopath
effect
cpe
induc
viru
hev
posit
fece
suspens
centrifug
g
c
min
filter
microfilt
follow
treatment
penicillin
streptomycin
h
viru
serial
dilut
dilut
ad
cell
triplic
day
infect
viral
cell
cultur
infecti
dose
ccdi
calcul
use
reed
muench
method
hev
infect
challeng
cell
transfect
sirna
describ
h
inocul
cell
challeng
hev
ccid
h
inocul
viru
replac
fresh
growth
medium
infect
observ
everi
h
cell
transfect
effici
evalu
transfect
fluorlabel
gapdh
sirna
cell
harvest
h
postinfect
realtim
qpcr
analysi
h
postinfect
western
blot
assay
fortyeight
hour
postinocul
cultur
medium
remov
cell
lyse
total
rna
isol
trizol
invitrogen
america
accord
manufactur
direct
revers
transcript
analysi
carri
use
amv
revers
transcriptas
xl
realtim
pcr
takara
japan
accord
manufactur
direct
protocol
revers
transcript
reaction
perform
describ
except
forward
primer
revers
primer
synthes
first
strand
cdna
l
ad
templat
realtim
qpcr
use
premix
ex
taq
tm
perfect
realtim
takara
japan
accord
manufactur
direct
probe
accord
jothikumar
et
al
mixtur
react
c
follow
c
c
repeat
cycl
product
expect
bp
housekeep
gene
gapdh
serv
load
control
realtim
qpcr
analysi
perform
abi
prism
realtim
pcr
system
america
procedur
perform
triplic
data
express
mean
percentag
hev
mrna
express
analyz
compar
normal
control
cell
harvest
h
postinocul
lyse
lysi
buffer
mm
triscl
ph
mm
nacl
tritonx
gml
aprotinin
gml
phenylmethylsulfonyl
fluorid
equival
amount
total
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
electrophoret
transfer
onto
nitrocellulos
membran
nonspecificbind
site
block
skim
milk
membran
incub
primari
antibodi
c
overnight
primari
antibodi
hev
abr
america
dilut
goatrabbit
igg
conjug
hrp
use
secondari
antibodi
promega
america
dilut
gapdh
protein
serv
load
control
band
expos
xray
film
supersign
west
pico
trial
kit
pierc
america
twentyon
week
piglet
g
purchas
shanghai
jiao
tong
univers
maintain
pathogenfre
anim
facil
studi
protocol
approv
anim
care
use
committe
acuc
shanghai
jiao
tong
univers
follow
guidelin
shanghai
jiao
tong
univers
studi
piglet
test
antihev
igm
igg
elisa
wantai
china
piglet
confirm
seroneg
includ
studi
twentyon
piglet
randomli
distribut
seven
group
three
piglet
per
group
group
normal
control
one
piglet
group
inject
intraven
plasmid
serv
report
identifi
shrna
plasmid
express
vivo
group
inject
intraven
steril
pb
group
inject
intraven
g
five
plasmid
shrnascrambl
respect
tabl
plasmid
dilut
steril
pb
piglet
group
intraven
inocul
ml
hev
ml
per
pig
h
later
fece
collect
daili
hev
rna
detect
piglet
human
euthan
follow
guidelin
care
use
laboratori
anim
day
postinocul
piglet
group
confirm
pass
hev
rna
fece
blood
collect
rtnpcr
detect
elisa
test
enzym
activ
assay
autom
biochemistri
analyz
liver
spleen
kidney
collect
rtnpcr
detect
store
c
use
indirect
immunofluoresc
observ
frozen
cut
section
histopatholog
examin
fix
immedi
neutral
buffer
formalin
hev
igm
igg
separ
determin
use
commerci
elisa
kit
wantai
china
accord
manufactur
direct
kit
contain
posit
neg
control
cutoff
valu
igm
assay
determin
base
igg
plu
mean
od
valu
sera
normal
control
piglet
deviat
total
rna
fece
extract
trizol
invitrogen
america
accord
manufactur
instruct
revers
transcript
pcr
perform
describ
frozen
tissu
cut
section
indirect
immunofluoresc
observ
hevspecif
primari
antibodi
abr
america
dilut
whose
recombin
protein
complet
conserv
four
genotyp
design
detect
capsid
protein
hev
genotyp
ad
section
incub
c
min
wash
phosphat
buffer
solut
pb
fitclabel
goat
antirabbit
secondari
antibodi
dingguo
china
dilut
ad
incub
c
min
wash
pb
slide
observ
nikon
te
fluoresc
microscop
specimen
test
duplic
posit
control
specimen
hev
infect
swine
neg
control
specimen
normal
control
piglet
activ
alt
ast
level
tbil
sera
measur
autom
biochemistri
analyz
olympu
japan
tissu
fix
neutral
buffer
formalin
section
stain
hematoxylin
eosin
tissu
section
examin
compar
normal
control
bp
rdrp
gene
hev
nt
amplifi
rtnpcr
introduc
vector
restrict
site
bamhibstxi
yield
recombin
plasmid
identifi
digest
sequenc
suppress
rdrp
mrna
level
observ
fluoresc
microscopi
h
posttransfect
fig
decreas
hev
mrna
determin
h
postinocul
realtim
qpcr
fig
rel
reduct
mrna
silenc
cell
unsilenc
cell
calcul
accord
pfaffl
method
pfaffl
transcript
level
rdrp
mrna
decreas
cell
transfect
respect
howev
signific
chang
note
cell
transfect
scrambl
sirna
fig
mrna
level
gapdh
significantli
chang
either
nontransfect
transfect
cell
analyz
suppress
effici
protein
level
cell
collect
western
blot
analysi
h
postinocul
inocul
cell
express
expect
protein
band
kda
fig
cell
pretransfect
hev
specif
sirna
show
protein
band
decreas
intens
fig
band
react
antihev
rdrp
antibodi
western
blot
analysi
show
hev
protein
express
significantli
reduc
cell
pretransfect
hev
specif
sirna
especi
fig
compar
cell
transfect
sirna
inocul
gapdh
use
load
control
experi
fig
piglet
group
inocul
hev
group
preinject
group
preinject
shrnascrambl
develop
sever
hepat
icter
viral
hepat
diarrhea
consist
previou
studi
aggarw
krawczynski
feagin
et
al
piglet
preinject
show
mild
viral
hepat
howev
symptom
observ
piglet
inject
express
plasmid
elev
antihev
igm
detect
infect
piglet
group
group
one
member
group
howev
none
piglet
inject
hev
specif
express
plasmid
show
antihev
igm
antihev
igg
detect
piglet
studi
hev
rna
detect
fece
group
hev
inocul
day
postinocul
human
euthan
consist
previou
studi
feagin
et
al
kasorndorkbua
et
al
hev
rna
also
detect
group
preinject
shrnascrambl
one
member
group
preinject
fece
day
hev
rna
detect
group
preinject
throughout
entir
studi
tabl
presenc
hev
antigen
observ
indirect
immunofluoresc
liver
spleen
kidney
fig
inocul
group
group
sign
observ
normal
control
group
hev
antigen
liver
spleen
kidney
obvious
reduc
express
plasmid
fig
sera
separ
enzym
activ
character
use
autom
biochemistri
analyz
infect
piglet
show
signific
elev
alt
activ
time
higher
upper
limit
normal
control
activ
ast
time
higher
upper
limit
level
tbil
time
higher
upper
limit
normal
control
activ
alt
p
ast
p
tbil
p
significantli
decreas
piglet
inject
express
plasmid
compar
hev
infect
group
fig
hepat
injuri
caus
hev
infect
observ
infect
piglet
enlarg
liver
fill
inflammatori
exud
hepatocyt
necrosi
liver
hemorrhag
fig
enlarg
spleen
display
multipl
hemorrhag
focal
necrosi
lymphocyt
prolifer
fig
degre
hepat
splenet
injuri
clearli
attenu
piglet
inject
express
plasmid
fig
express
plasmid
show
protect
effect
well
fig
howev
piglet
inject
shrnascrambl
express
plasmid
show
increas
protect
fig
injuri
liver
spleen
normal
control
group
fig
hepat
e
infect
consider
concern
antibodi
found
global
hev
one
import
caus
acut
clinic
hepat
adult
develop
countri
tei
et
al
nonstructur
polyprotein
rdrp
viru
involv
earliest
stage
viral
replic
arbuthnot
thompson
demarini
et
al
zhong
et
al
brockway
et
al
rdrp
may
prove
best
target
best
time
strategi
suppress
hev
replic
rna
interfer
antivir
therapi
tool
rna
interfer
great
promis
kumar
et
al
lupberg
et
al
ni
et
al
repres
realist
approach
suppress
recalcitr
viral
infect
induc
hev
current
studi
hevspecif
sirna
effect
specif
inhibit
express
hev
rdrp
gene
cell
cell
transfect
hev
specif
capabl
prevent
infect
host
cell
hev
vitro
find
indic
protocol
may
effect
antivir
strategi
hev
infect
demonstr
equal
effici
vivo
suppress
hev
infect
piglet
follow
inject
hevspecif
shrna
express
plasmid
particularli
encourag
group
piglet
inject
express
plasmid
hev
rna
detect
group
throughout
entir
studi
addit
hev
antigen
obvious
reduc
liver
spleen
kidney
piglet
activ
alt
ast
level
tbil
clear
reduct
vivo
infect
symptom
strong
indic
potenti
use
rnai
approach
altern
rel
unsuccess
vaccin
approach
attempt
previous
conclus
find
present
studi
strongli
suggest
hevspecif
sirna
capabl
inhibit
hev
express
replic
vitro
cell
vivo
piglet
thu
rnai
look
extrem
promis
potenti
antivir
therapi
suppress
hev
infect
